Bank of New York Mellon’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-635,396
| Closed | -$9.52M | – | 4363 |
|
|
2016
Q2 | $9.52M | Sell |
635,396
-76,544
| -11% | -$1.15M | ﹤0.01% | 1876 |
|
|
2016
Q1 | $8.66M | Buy |
711,940
+445,247
| +167% | +$5.42M | ﹤0.01% | 1913 |
|
|
2015
Q4 | $4.24M | Buy |
266,693
+19,657
| +8% | +$313K | ﹤0.01% | 2315 |
|
|
2015
Q3 | $3.79M | Buy |
247,036
+29,175
| +13% | +$447K | ﹤0.01% | 2390 |
|
|
2015
Q2 | $5.3M | Buy |
217,861
+8,716
| +4% | +$212K | ﹤0.01% | 2320 |
|
|
2015
Q1 | $4.86M | Buy |
209,145
+6,628
| +3% | +$154K | ﹤0.01% | 2329 |
|
|
2014
Q4 | $5.09M | Sell |
202,517
-35,414
| -15% | -$889K | ﹤0.01% | 2304 |
|
|
2014
Q3 | $7.4M | Sell |
237,931
-4,643
| -2% | -$144K | ﹤0.01% | 2080 |
|
|
2014
Q2 | $6.27M | Buy |
242,574
+98,243
| +68% | +$2.54M | ﹤0.01% | 2195 |
|
|
2014
Q1 | $3.37M | Buy |
144,331
+6,869
| +5% | +$161K | ﹤0.01% | 2546 |
|
|
2013
Q4 | $3.49M | Buy |
137,462
+34,889
| +34% | +$886K | ﹤0.01% | 2523 |
|
|
2013
Q3 | $2.09M | Buy |
102,573
+2,368
| +2% | +$48.3K | ﹤0.01% | 2819 |
|
|
2013
Q2 | $2.1M | Buy |
+100,205
| New | +$2.1M | ﹤0.01% | 2755 |
|